Evidence map›Paper›PMID 36415470›Full record

ArticlebioRxiv : the preprint server for biology2023

Inflammation durably imprints memory CD4+ T cells.

Sophie L Gray-Gaillard, Sabrina Solis, Han M Chen, Clarice Monteiro, Grace Ciabattoni, Marie I Samanovic, Amber R Cornelius, Tijaana Williams, Emilie Geesey, Miguel Rodriguez and 5 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Sophie L Gray-GaillardDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Sabrina SolisDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Han M ChenDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Clarice MonteiroDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Grace CiabattoniDepartment of Microbiology, New York University School of Medicine; New York, NY, USA.
Marie I SamanovicDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Amber R CorneliusDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Tijaana WilliamsDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Emilie GeeseyDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Miguel RodriguezDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Mila Brum OrtigozaDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Ellie N IvanovaDepartment of Pathology, New York University School of Medicine; New York, NY, USA.
Sergei B KoralovDepartment of Pathology, New York University School of Medicine; New York, NY, USA.
Mark J MulliganDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
Ramin Sedaghat HeratiDepartment of Medicine, New York University Grossman School of Medicine; New York, NY, USA.
New York Proton Center · US

Funding

Project-005UL1TR001445 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI BREDELLA, MIRIAM ANTOINETTE, HOCHMAN, JUDITH S · 2015 to 2025
$103.5M
Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARK Reid PHILIPS · 1985 to 2026
$83.1M
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities75N93021C00014 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GARCIA-SASTRE, ADOLFO · 2021 to 2025
$62.6M
Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI GEORG Michael LAUER · 2009 to 2026
$48.1M
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) - DMID 21-0012UM1AI148574 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Angelica Cifuentes Kottkamp, Anoma Nellore · 2020 to 2026
$23.9M
A systems immunology approach for predicting poor responses to Hepatitis B vaccinationR01AI158617 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HERATI, RAMIN · 2021 to 2025
$3.9M
Microbial triggers and molecular mechanisms of Th17 mediated airway inflammation-Resubmission-1R01HL125816 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KORALOV, SERGEI BORISOVICH · 2015 to 2019
$3.3M
Biology of Influenza Virus TransmissionK08AI141759 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ORTIGOZA, MILA BRUM · 2019 to 2023
$939k
Delineating The Differences Between Short-Lived And Long-Lived Plasma CellsR21AI137752 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KORALOV, SERGEI BORISOVICH · 2019 to 2020
$466k
Non-coding RNAs in B lymphocyte development and functionR21AI110830 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI KORALOV, SERGEI BORISOVICH · 2014 to 2014
$170k
NCATS NIH HHS UL1 TR001445NCI NIH HHS P30 CA016087NHLBI NIH HHS R01 HL125816NIAID NIH HHS 75N93021C00014NIAID NIH HHS K08 AI141759NIAID NIH HHS R01 AI158617NIAID NIH HHS R21 AI110830NIAID NIH HHS R21 AI137752NIAID NIH HHS U19 AI082630NIAID NIH HHS UM1 AI148574
6 · The paper itself

Abstract

Adaptive immune responses are induced by vaccination and infection, yet little is known about how CD4+ T cell memory differs when primed in these two contexts. Notably, viral infection is generally associated with higher levels of systemic inflammation than is vaccination. To assess whether the inflammatory milieu at the time of CD4+ T cell priming has long-term effects on memory, we compared Spike-specific memory CD4+ T cells in 22 individuals around the time of the participants' third SARS-CoV-2 mRNA vaccination, with stratification by whether the participants' first exposure to Spike was via virus or mRNA vaccine. Multimodal single-cell profiling of Spike-specific CD4+ T cells revealed 755 differentially expressed genes that distinguished infection- and vaccine-primed memory CD4+ T cells. Spike-specific CD4+ T cells from infection-primed individuals had strong enrichment for cytotoxicity and interferon signaling genes, whereas Spike-specific CD4+ T cells from vaccine-primed individuals were enriched for proliferative pathways by gene set enrichment analysis. Moreover, Spike-specific memory CD4+ T cells established by infection had distinct epigenetic landscapes driven by enrichment of IRF-family transcription factors, relative to T cells established by mRNA vaccination. This transcriptional imprint was minimally altered following subsequent mRNA vaccination or breakthrough infection, reflecting the strong bias induced by the inflammatory environment during initial memory differentiation. Together, these data suggest that the inflammatory context during CD4+ T cell priming is durably imprinted in the memory state at transcriptional and epigenetic levels, which has implications for personalization of vaccination based on prior infection history.

Identifiers

PMID36415470
PMCPMC9681040
OpenAlexW4309146118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.